Author: SWARNALATHA B
Clini Resource Openings Details Below. Established in 2017, Clini Resource is the creation of seasoned industrial pharmacovigilance experts, showcasing extensive experience across various functions. Our founders and leaders, with an unrivaled reputation in the industry and a global network of expert associates, embody the belief that “The …
Traders and investors investing in the Indian markets are expected to focus on macroeconomic data and the final phase of the July to September quarter results. The week ahead has several important companies poised to announce their second-quarter results as we move towards the last phase of the earnings season. …
Shares of index heavyweight Reliance Industries (RIL) have been falling since July and have tumbled by 7% in the last one month alone. The shares also came under pressure following the company’s Q2 results, wherein it reported a 5% fall in its net profit to Rs …
Nestle, the Switzerland-based FMCG company, is a powerful force in the consumer goods sector globally. Most importantly, it is also a household name with a significant influence and footprint in India as well. Nestle’s Troubled Past Recently, the brand that previously invited trouble over lead content …
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years.Our credo and our purpose …
Cipla managing director and global CEO Umang Vohra is optimistic about the opportunities arising for Indian pharmaceutical companies, particularly in the face of expected changes in US trade policies when Donald Trump takes over as the president in January. Speaking to Moneycontrol, Vohra said the US biosecurity act, which restricts US pharma companies …
Stock Market Today: Shares of Aarti Industries, the flagship company of the Aarti Group, tumbled 10% to ₹427 per share, hitting a 4-year low in trade on Monday, November 11. This decline followed the company’s disastrous performance in the September quarter, with both net profit and EBITDA reaching …
The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 23000 people worldwide and is …
Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Vacancy details: Department: …
Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
error: Content is protected !!
